Source: Annual Congress 2011 - New advances in smoking cessation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Fagerstrom (Kågeröd, Sweden). How to optimise the efficacy of pharmacological treatments?. Annual Congress 2011 - New advances in smoking cessation

Member's Comments

No comment yet.

Related content which might interest you: How to manage side-effects of targeted therapies? Source: Annual Congress 2010 - PG7 Postgraduate Course: How to manage treatment complications of lung cancer Year: 2010 More hope for cure by individualised adjuvant treatment? Source: Annual Congress 2010 - Customised chemotherapy for lung cancer Year: 2010 Did inappropriate delivery systems hamper therapeutic efficacy of di-sodium-cromo-glycate (DSCG)? Time for a reappraisal Source: Annual Congress 2011 - Treating childhood asthma Year: 2011 How to manage side-effects of radiotherapy? Source: Annual Congress 2010 - PG7 Postgraduate Course: How to manage treatment complications of lung cancer Year: 2010 Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Which therapeutic options when CPAP fails?  Source: ERS Course 2017 - Paediatric noninvasive ventilation Year: 2017 Multidimensional approaches to asthma: the need to look beyond drug treatments Source: Annual Congress 2010 - Breathing therapies for asthma Year: 2010 Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies? Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Overview of treatment modalities Source: Annual Congress 2011 - PG15 Treatment of obstructive sleep apnoea Year: 2011 Overview of treatment modalities Source: Annual Congress 2010 - PG19 Postgraduate Course: Treatment of obstructive sleep apnoea Year: 2010 Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? Source: Eur Respir J 2004; 24: 1-2 Year: 2004 Time to ban short-acting ß-agonists and use anti-inflammatory treatment as required to improve outcomes Source: Virtual Congress 2021 – Wheezing illnesses along the life span Year: 2021 Efficacy and safety of antibiotic treatment of stable COPD Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations Year: 2010 What could we learn from ongoing therapeutic trials? Source: ERS Research Seminar Year: 2015 Impact of phenotyping upon treatment choices in childhood Source: Annual Congress 2010 - A new understanding of childhood wheeze phenotypes Year: 2010 Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010